Omalizumab, an anti-IgE antibody, suppresses airway inflammation in mild allergic asthma via a reduction in mast cell surface-associated interlukin-4

Category Primary study
JournalAllergy & Clinical Immunology International
Year 2003
This article has no abstract
Epistemonikos ID: fcbbac88924da073e40f9ba76944e55ca01166ee
First added on: Sep 14, 2017